ID   NTRK1_RAT               Reviewed;         799 AA.
AC   P35739;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   02-OCT-2024, entry version 219.
DE   RecName: Full=High affinity nerve growth factor receptor;
DE            EC=2.7.10.1;
DE   AltName: Full=Neurotrophic tyrosine kinase receptor type 1;
DE   AltName: Full=Slow nerve growth factor receptor;
DE   AltName: Full=p140-TrkA;
DE            Short=Trk-A;
DE   Flags: Precursor;
GN   Name=Ntrk1; Synonyms=Trk, Trka;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM TRKA-II), FUNCTION AS RECEPTOR FOR NGF,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=1312719; DOI=10.1073/pnas.89.6.2374;
RA   Meakin S.O., Suter U., Drinkwater C.C., Welcher A.A., Shooter E.M.;
RT   "The rat trk protooncogene product exhibits properties characteristic of
RT   the slow nerve growth factor receptor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:2374-2378(1992).
RN   [2]
RP   ALTERNATIVE SPLICING (ISOFORMS TRKA-I AND TRKA-II).
RX   PubMed=8325889; DOI=10.1016/s0021-9258(18)82449-8;
RA   Barker P.A., Lomen-Hoerth C., Gensch E.M., Meakin S.O., Glass D.J.,
RA   Shooter E.M.;
RT   "Tissue-specific alternative splicing generates two isoforms of the trkA
RT   receptor.";
RL   J. Biol. Chem. 268:15150-15157(1993).
RN   [3]
RP   FUNCTION AS RECEPTOR FOR NGF, AND SUBCELLULAR LOCATION.
RX   PubMed=1850821; DOI=10.1038/350678a0;
RA   Hempstead B.L., Martin-Zanca D., Kaplan D.R., Parada L.F., Chao M.V.;
RT   "High-affinity NGF binding requires coexpression of the trk proto-oncogene
RT   and the low-affinity NGF receptor.";
RL   Nature 350:678-683(1991).
RN   [4]
RP   INTERACTION WITH SHC1.
RX   PubMed=8155326; DOI=10.1016/0896-6273(94)90223-2;
RA   Stephens R.M., Loeb D.M., Copeland T.D., Pawson T., Greene L.A.,
RA   Kaplan D.R.;
RT   "Trk receptors use redundant signal transduction pathways involving SHC and
RT   PLC-gamma 1 to mediate NGF responses.";
RL   Neuron 12:691-705(1994).
RN   [5]
RP   INTERACTION WITH PLCG1; SHC1; SH2B1 AND SH2B2, AND MUTAGENESIS OF VAL-527.
RX   PubMed=9856458; DOI=10.1016/s0896-6273(00)80620-0;
RA   Qian X., Riccio A., Zhang Y., Ginty D.D.;
RT   "Identification and characterization of novel substrates of Trk receptors
RT   in developing neurons.";
RL   Neuron 21:1017-1029(1998).
RN   [6]
RP   INTERACTION WITH SQSTM1.
RX   PubMed=11244088; DOI=10.1074/jbc.c000869200;
RA   Wooten M.W., Seibenhener M.L., Mamidipudi V., Diaz-Meco M.T., Barker P.A.,
RA   Moscat J.;
RT   "The atypical protein kinase C-interacting protein p62 is a scaffold for
RT   NF-kappaB activation by nerve growth factor.";
RL   J. Biol. Chem. 276:7709-7712(2001).
RN   [7]
RP   INTERACTION WITH KIDINS220.
RX   PubMed=11150334; DOI=10.1523/jneurosci.21-01-00176.2001;
RA   Kong H., Boulter J., Weber J.L., Lai C., Chao M.V.;
RT   "An evolutionarily conserved transmembrane protein that is a novel
RT   downstream target of neurotrophin and ephrin receptors.";
RL   J. Neurosci. 21:176-185(2001).
RN   [8]
RP   INTERACTION WITH SQSTM1, SUBCELLULAR LOCATION, AND DOMAIN.
RX   PubMed=12471037; DOI=10.1074/jbc.m208468200;
RA   Geetha T., Wooten M.W.;
RT   "Association of the atypical protein kinase C-interacting protein p62/ZIP
RT   with nerve growth factor receptor TrkA regulates receptor trafficking and
RT   Erk5 signaling.";
RL   J. Biol. Chem. 278:4730-4739(2003).
RN   [9]
RP   INTERACTION WITH KIDINS220, AND DOMAIN.
RX   PubMed=15167895; DOI=10.1038/sj.emboj.7600253;
RA   Arevalo J.C., Yano H., Teng K.K., Chao M.V.;
RT   "A unique pathway for sustained neurotrophin signaling through an ankyrin-
RT   rich membrane-spanning protein.";
RL   EMBO J. 23:2358-2368(2004).
RN   [10]
RP   INTERACTION WITH NGFR AND KIDINS220, AND DOMAIN.
RX   PubMed=15378608; DOI=10.1002/jnr.20262;
RA   Chang M.-S., Arevalo J.C., Chao M.V.;
RT   "Ternary complex with Trk, p75, and an ankyrin-rich membrane spanning
RT   protein.";
RL   J. Neurosci. Res. 78:186-192(2004).
RN   [11]
RP   ACTIVITY REGULATION, AND INTERACTION WITH SH2D1A.
RX   PubMed=16223723; DOI=10.1074/jbc.m506554200;
RA   Lo K.Y., Chin W.H., Ng Y.P., Cheng A.W., Cheung Z.H., Ip N.Y.;
RT   "SLAM-associated protein as a potential negative regulator in Trk
RT   signaling.";
RL   J. Biol. Chem. 280:41744-41752(2005).
RN   [12]
RP   INTERACTION WITH RAB7A, AND SUBCELLULAR LOCATION.
RX   PubMed=16306406; DOI=10.1523/jneurosci.2029-05.2005;
RA   Saxena S., Bucci C., Weis J., Kruttgen A.;
RT   "The small GTPase Rab7 controls the endosomal trafficking and neuritogenic
RT   signaling of the nerve growth factor receptor TrkA.";
RL   J. Neurosci. 25:10930-10940(2005).
RN   [13]
RP   INTERACTION WITH PTPRS.
RX   PubMed=17967490; DOI=10.1016/j.bbamcr.2007.06.008;
RA   Faux C., Hawadle M., Nixon J., Wallace A., Lee S., Murray S., Stoker A.;
RT   "PTPsigma binds and dephosphorylates neurotrophin receptors and can
RT   suppress NGF-dependent neurite outgrowth from sensory neurons.";
RL   Biochim. Biophys. Acta 1773:1689-1700(2007).
RN   [14]
RP   IDENTIFICATION IN A COMPLEX WITH KIDINS220; MAGI2 AND RAPGEF2, INTERACTION
RP   WITH RAPGEF2, AND SUBCELLULAR LOCATION.
RX   PubMed=17724123; DOI=10.1083/jcb.200610073;
RA   Hisata S., Sakisaka T., Baba T., Yamada T., Aoki K., Matsuda M., Takai Y.;
RT   "Rap1-PDZ-GEF1 interacts with a neurotrophin receptor at late endosomes,
RT   leading to sustained activation of Rap1 and ERK and neurite outgrowth.";
RL   J. Cell Biol. 178:843-860(2007).
RN   [15]
RP   INTERACTION WITH NRADD.
RX   PubMed=18624909; DOI=10.1111/j.1471-4159.2008.05539.x;
RA   Wong A.W., Willingham M., Xiao J., Kilpatrick T.J., Murray S.S.;
RT   "Neurotrophin receptor homolog-2 regulates nerve growth factor signaling.";
RL   J. Neurochem. 106:1964-1976(2008).
RN   [16]
RP   FUNCTION IN CELL DEATH.
RX   PubMed=20811452; DOI=10.1038/nature09336;
RA   Nikoletopoulou V., Lickert H., Frade J.M., Rencurel C., Giallonardo P.,
RA   Zhang L., Bibel M., Barde Y.A.;
RT   "Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB
RT   does not.";
RL   Nature 467:59-63(2010).
RN   [17]
RP   INTERACTION WITH GGA3, AND SUBCELLULAR LOCATION.
RX   PubMed=26446845; DOI=10.1091/mbc.e15-02-0087;
RA   Li X., Lavigne P., Lavoie C.;
RT   "GGA3 mediates TrkA endocytic recycling to promote sustained Akt
RT   phosphorylation and cell survival.";
RL   Mol. Biol. Cell 26:4412-4426(2015).
RN   [18]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH NTRK1/TRKA.
RX   PubMed=31440771; DOI=10.1007/s00018-019-03282-3;
RA   Ferrero Restelli F., Fontanet P.A., De Vincenti A.P., Falzone T.L.,
RA   Ledda F., Paratcha G.;
RT   "Tetraspanin1 promotes NGF signaling by controlling TrkA receptor
RT   proteostasis.";
RL   Cell. Mol. Life Sci. 77:2217-2233(2020).
CC   -!- FUNCTION: Receptor tyrosine kinase involved in the development and the
CC       maturation of the central and peripheral nervous systems through
CC       regulation of proliferation, differentiation and survival of
CC       sympathetic and nervous neurons. High affinity receptor for NGF which
CC       is its primary ligand (PubMed:1312719, PubMed:1850821,
CC       PubMed:31440771). Can also bind and be activated by NTF3/neurotrophin-
CC       3. However, NTF3 only supports axonal extension through NTRK1 but has
CC       no effect on neuron survival. Upon dimeric NGF ligand-binding,
CC       undergoes homodimerization, autophosphorylation and activation.
CC       Recruits, phosphorylates and/or activates several downstream effectors
CC       including SHC1, FRS2, SH2B1, SH2B2 and PLCG1 that regulate distinct
CC       overlapping signaling cascades driving cell survival and
CC       differentiation. Through SHC1 and FRS2 activates a GRB2-Ras-MAPK
CC       cascade that regulates cell differentiation and survival. Through PLCG1
CC       controls NF-Kappa-B activation and the transcription of genes involved
CC       in cell survival. Through SHC1 and SH2B1 controls a Ras-PI3 kinase-AKT1
CC       signaling cascade that is also regulating survival. In absence of
CC       ligand and activation, may promote cell death, making the survival of
CC       neurons dependent on trophic factors. {ECO:0000250|UniProtKB:P04629,
CC       ECO:0000250|UniProtKB:Q3UFB7, ECO:0000269|PubMed:1312719,
CC       ECO:0000269|PubMed:1850821, ECO:0000269|PubMed:20811452}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- ACTIVITY REGULATION: The pro-survival signaling effect of NTRK1 in
CC       neurons requires its endocytosis into signaling early endosomes and its
CC       retrograde axonal transport. This is regulated by different proteins
CC       including CFL1, RAC1 and SORT1. NTF3 is unable to induce this signaling
CC       probably due to the lability of the NTF3-NTRK1 complex in endosomes (By
CC       similarity). SH2D1A inhibits the autophosphorylation of the receptor,
CC       and alters the recruitment and activation of downstream effectors and
CC       signaling cascades. Regulated by NGFR (By similarity).
CC       {ECO:0000250|UniProtKB:Q3UFB7}.
CC   -!- SUBUNIT: Exists in a dynamic equilibrium between monomeric (low
CC       affinity) and dimeric (high affinity) structures. Homodimerization is
CC       induced by binding of a NGF dimer (By similarity). Found in a complex,
CC       at least composed of KIDINS220, MAGI2, NTRK1 and RAPGEF2; the complex
CC       is mainly formed at late endosomes in a nerve growth factor (NGF)-
CC       dependent manner (PubMed:17724123). Interacts with RAPGEF2; the
CC       interaction is strengthened after NGF stimulation (PubMed:17724123).
CC       Interacts with SQSTM1; bridges NTRK1 to NGFR. Forms a ternary complex
CC       with NGFR and KIDINS220; this complex is affected by the expression
CC       levels of KIDINS220 and an increase in KIDINS220 expression leads to a
CC       decreased association of NGFR and NTRK1. Interacts (phosphorylated upon
CC       activation by NGF) with SHC1; mediates SHC1 phosphorylation and
CC       activation. Interacts (phosphorylated upon activation by NGF) with
CC       PLCG1; mediates PLCG1 phosphorylation and activation. Interacts
CC       (phosphorylated) with SH2B1 and SH2B2. Interacts with GRB2. Interacts
CC       with PIK3R1. Interacts with FRS2. Interacts with SORT1; may regulate
CC       NTRK1 anterograde axonal transport. Interacts with SH2D1A; regulates
CC       NTRK1. Interacts with NRADD (PubMed:18624909). Interacts with RAB7A
CC       (PubMed:16306406). Interacts with PTPRS (PubMed:17967490). Interacts
CC       with USP36; USP36 does not deubiquitinate NTRK1 (By similarity).
CC       Interacts with GGA3 (PubMed:26446845). Interacts with TSPAN1; this
CC       interaction promotes NTRK1 stability (PubMed:31440771).
CC       {ECO:0000250|UniProtKB:P04629, ECO:0000269|PubMed:11150334,
CC       ECO:0000269|PubMed:11244088, ECO:0000269|PubMed:12471037,
CC       ECO:0000269|PubMed:15167895, ECO:0000269|PubMed:15378608,
CC       ECO:0000269|PubMed:16223723, ECO:0000269|PubMed:16306406,
CC       ECO:0000269|PubMed:17724123, ECO:0000269|PubMed:17967490,
CC       ECO:0000269|PubMed:18624909, ECO:0000269|PubMed:26446845,
CC       ECO:0000269|PubMed:31440771, ECO:0000269|PubMed:8155326,
CC       ECO:0000269|PubMed:9856458}.
CC   -!- INTERACTION:
CC       P35739; P62994: Grb2; NbExp=6; IntAct=EBI-976667, EBI-401775;
CC       P35739; P07174: Ngfr; NbExp=2; IntAct=EBI-976667, EBI-1038810;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:1312719,
CC       ECO:0000269|PubMed:16306406, ECO:0000269|PubMed:1850821,
CC       ECO:0000269|PubMed:26446845, ECO:0000269|PubMed:31440771}; Single-pass
CC       type I membrane protein {ECO:0000305|PubMed:1850821}. Early endosome
CC       membrane {ECO:0000269|PubMed:17724123, ECO:0000269|PubMed:26446845};
CC       Single-pass type I membrane protein {ECO:0000305}. Late endosome
CC       membrane {ECO:0000269|PubMed:17724123, ECO:0000269|PubMed:26446845};
CC       Single-pass type I membrane protein {ECO:0000305}. Recycling endosome
CC       membrane {ECO:0000269|PubMed:26446845}; Single-pass type I membrane
CC       protein {ECO:0000305}. Note=Internalized to endosomes upon binding of
CC       NGF or NTF3 and further transported to the cell body via a retrograde
CC       axonal transport. Localized at cell membrane and early endosomes before
CC       nerve growth factor (NGF) stimulation (PubMed:17724123,
CC       PubMed:26446845). Recruited to late endosomes after NGF stimulation
CC       (PubMed:17724123, PubMed:26446845). Colocalized with RAPGEF2 at late
CC       endosomes (PubMed:17724123). {ECO:0000269|PubMed:17724123,
CC       ECO:0000269|PubMed:26446845}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Both isoforms have similar biological properties.;
CC       Name=TrkA-II;
CC         IsoId=P35739-1; Sequence=Displayed;
CC       Name=TrkA-I;
CC         IsoId=P35739-2; Sequence=VSP_002900;
CC   -!- TISSUE SPECIFICITY: Isoform Trka-II is primarily expressed in neuronal
CC       cells; isoform Trka-I is found in non-neuronal tissues.
CC   -!- DOMAIN: The transmembrane domain mediates interaction with KIDINS220.
CC       {ECO:0000269|PubMed:12471037, ECO:0000269|PubMed:15167895,
CC       ECO:0000269|PubMed:15378608}.
CC   -!- DOMAIN: The extracellular domain mediates interaction with NGFR.
CC       {ECO:0000269|PubMed:15378608}.
CC   -!- PTM: Ligand-mediated autophosphorylation. Interaction with SQSTM1 is
CC       phosphotyrosine-dependent. Autophosphorylation at Tyr-499 mediates
CC       interaction and phosphorylation of SHC1.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:P04629}.
CC   -!- PTM: Ubiquitinated. Undergoes polyubiquitination upon activation;
CC       regulated by NGFR. Ubiquitination by NEDD4L leads to degradation (By
CC       similarity). Ubiquitination regulates the internalization of the
CC       receptor (By similarity). {ECO:0000250|UniProtKB:P04629,
CC       ECO:0000250|UniProtKB:Q3UFB7}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Insulin receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M85214; AAA42286.1; -; mRNA.
DR   EMBL; L12225; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PIR; A41981; TVRTTB.
DR   RefSeq; NP_067600.1; NM_021589.1. [P35739-1]
DR   AlphaFoldDB; P35739; -.
DR   SMR; P35739; -.
DR   BioGRID; 248731; 24.
DR   CORUM; P35739; -.
DR   DIP; DIP-5716N; -.
DR   IntAct; P35739; 7.
DR   MINT; P35739; -.
DR   STRING; 10116.ENSRNOP00000018961; -.
DR   BindingDB; P35739; -.
DR   ChEMBL; CHEMBL4220; -.
DR   GlyCosmos; P35739; 11 sites, No reported glycans.
DR   GlyGen; P35739; 11 sites.
DR   iPTMnet; P35739; -.
DR   PhosphoSitePlus; P35739; -.
DR   PaxDb; 10116-ENSRNOP00000018961; -.
DR   Ensembl; ENSRNOT00000018961.4; ENSRNOP00000018961.2; ENSRNOG00000013953.9. [P35739-2]
DR   Ensembl; ENSRNOT00000115670.1; ENSRNOP00000079821.1; ENSRNOG00000013953.9. [P35739-1]
DR   Ensembl; ENSRNOT00055039763; ENSRNOP00055032286; ENSRNOG00055023126. [P35739-1]
DR   Ensembl; ENSRNOT00060054994; ENSRNOP00060045463; ENSRNOG00060031729. [P35739-1]
DR   Ensembl; ENSRNOT00065051271; ENSRNOP00065042210; ENSRNOG00065029663. [P35739-1]
DR   GeneID; 59109; -.
DR   KEGG; rno:59109; -.
DR   UCSC; RGD:620144; rat. [P35739-1]
DR   AGR; RGD:620144; -.
DR   CTD; 4914; -.
DR   RGD; 620144; Ntrk1.
DR   eggNOG; KOG1026; Eukaryota.
DR   GeneTree; ENSGT00940000159412; -.
DR   HOGENOM; CLU_000288_74_1_1; -.
DR   InParanoid; P35739; -.
DR   OMA; LTCHISA; -.
DR   OrthoDB; 1614410at2759; -.
DR   PhylomeDB; P35739; -.
DR   TreeFam; TF106465; -.
DR   BRENDA; 2.7.10.1; 5301.
DR   Reactome; R-RNO-170968; Frs2-mediated activation.
DR   Reactome; R-RNO-170984; ARMS-mediated activation.
DR   Reactome; R-RNO-177504; Retrograde neurotrophin signalling.
DR   Reactome; R-RNO-187042; TRKA activation by NGF.
DR   Reactome; R-RNO-198203; PI3K/AKT activation.
DR   PRO; PR:P35739; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000013953; Expressed in kidney and 10 other cell types or tissues.
DR   ExpressionAtlas; P35739; baseline and differential.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0009986; C:cell surface; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0005769; C:early endosome; IDA:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0005770; C:late endosome; IDA:UniProtKB.
DR   GO; GO:0031902; C:late endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0055037; C:recycling endosome; IDA:UniProtKB.
DR   GO; GO:0055038; C:recycling endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005004; F:GPI-linked ephrin receptor activity; IDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0019900; F:kinase binding; IPI:RGD.
DR   GO; GO:0048406; F:nerve growth factor binding; IDA:RGD.
DR   GO; GO:0010465; F:nerve growth factor receptor activity; ISS:UniProtKB.
DR   GO; GO:0043121; F:neurotrophin binding; IBA:GO_Central.
DR   GO; GO:0005166; F:neurotrophin p75 receptor binding; IPI:RGD.
DR   GO; GO:0005030; F:neurotrophin receptor activity; IBA:GO_Central.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IDA:MGI.
DR   GO; GO:0004675; F:transmembrane receptor protein serine/threonine kinase activity; TAS:Reactome.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; ISS:UniProtKB.
DR   GO; GO:0007411; P:axon guidance; IMP:RGD.
DR   GO; GO:0060385; P:axonogenesis involved in innervation; ISS:UniProtKB.
DR   GO; GO:0030183; P:B cell differentiation; ISO:RGD.
DR   GO; GO:0061368; P:behavioral response to formalin induced pain; ISO:RGD.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IDA:MGI.
DR   GO; GO:1990090; P:cellular response to nerve growth factor stimulus; IDA:UniProtKB.
DR   GO; GO:0071316; P:cellular response to nicotine; IDA:RGD.
DR   GO; GO:0007623; P:circadian rhythm; ISO:RGD.
DR   GO; GO:0050966; P:detection of mechanical stimulus involved in sensory perception of pain; IMP:RGD.
DR   GO; GO:0050965; P:detection of temperature stimulus involved in sensory perception of pain; IMP:RGD.
DR   GO; GO:0060384; P:innervation; ISO:RGD.
DR   GO; GO:0007611; P:learning or memory; IMP:RGD.
DR   GO; GO:0042490; P:mechanoreceptor differentiation; ISO:RGD.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; IMP:UniProtKB.
DR   GO; GO:0038180; P:nerve growth factor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; ISO:RGD.
DR   GO; GO:0051402; P:neuron apoptotic process; ISO:RGD.
DR   GO; GO:0048011; P:neurotrophin TRK receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0021553; P:olfactory nerve development; IEP:RGD.
DR   GO; GO:0038083; P:peptidyl-tyrosine autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; ISS:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; ISS:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; IBA:GO_Central.
DR   GO; GO:0043068; P:positive regulation of programmed cell death; IDA:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0046579; P:positive regulation of Ras protein signal transduction; ISS:UniProtKB.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; ISO:RGD.
DR   GO; GO:0051968; P:positive regulation of synaptic transmission, glutamatergic; IMP:RGD.
DR   GO; GO:0010623; P:programmed cell death involved in cell development; IDA:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:MGI.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0048678; P:response to axon injury; IEP:RGD.
DR   GO; GO:0051602; P:response to electrical stimulus; IDA:RGD.
DR   GO; GO:0051599; P:response to hydrostatic pressure; IEP:RGD.
DR   GO; GO:0035094; P:response to nicotine; IDA:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IDA:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IDA:RGD.
DR   GO; GO:0060009; P:Sertoli cell development; IMP:RGD.
DR   GO; GO:0007283; P:spermatogenesis; IEP:RGD.
DR   GO; GO:0048485; P:sympathetic nervous system development; ISS:UniProtKB.
DR   CDD; cd04971; IgI_TrKABC_d5; 1.
DR   Gene3D; 2.60.40.10; Immunoglobulins; 2.
DR   Gene3D; 3.80.10.10; Ribonuclease Inhibitor; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR020777; NTRK.
DR   InterPro; IPR020461; NTRK1.
DR   InterPro; IPR031635; NTRK_LRRCT.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR050122; RTK.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR002011; Tyr_kinase_rcpt_2_CS.
DR   PANTHER; PTHR24416:SF370; HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR; 1.
DR   PANTHER; PTHR24416; TYROSINE-PROTEIN KINASE RECEPTOR; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF13855; LRR_8; 1.
DR   Pfam; PF16920; LRRCT_2; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   PRINTS; PR01939; NTKRECEPTOR.
DR   PRINTS; PR01940; NTKRECEPTOR1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF48726; Immunoglobulin; 2.
DR   SUPFAM; SSF52058; L domain-like; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS00239; RECEPTOR_TYR_KIN_II; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell membrane; Developmental protein;
KW   Differentiation; Disulfide bond; Endosome; Glycoprotein;
KW   Immunoglobulin domain; Kinase; Leucine-rich repeat; Membrane; Neurogenesis;
KW   Nucleotide-binding; Phosphoprotein; Receptor; Reference proteome; Repeat;
KW   Signal; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase; Ubl conjugation.
FT   SIGNAL          1..32
FT                   /evidence="ECO:0000255"
FT   CHAIN           33..799
FT                   /note="High affinity nerve growth factor receptor"
FT                   /id="PRO_0000016725"
FT   TOPO_DOM        33..418
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        419..442
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        443..799
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REPEAT          90..113
FT                   /note="LRR 1"
FT   REPEAT          116..137
FT                   /note="LRR 2"
FT   DOMAIN          148..219
FT                   /note="LRRCT"
FT   DOMAIN          196..285
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          295..368
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          513..784
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          472..493
FT                   /note="Interaction with SQSTM1"
FT   ACT_SITE        653
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         519..527
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         547
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   SITE            499
FT                   /note="Interaction with SHC1"
FT                   /evidence="ECO:0000250"
FT   SITE            794
FT                   /note="Interaction with PLCG1"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         499
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P04629"
FT   MOD_RES         679
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P04629"
FT   MOD_RES         683
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P04629"
FT   MOD_RES         684
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P04629"
FT   MOD_RES         794
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P04629"
FT   CARBOHYD        67
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        121
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        190
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        204
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        255
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        264
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        320
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        325
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        341
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        361
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        404
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        36..41
FT                   /evidence="ECO:0000250|UniProtKB:P04629"
FT   DISULFID        40..50
FT                   /evidence="ECO:0000250|UniProtKB:P04629"
FT   DISULFID        154..193
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        217..267
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        302..348
FT                   /evidence="ECO:0000250|UniProtKB:P04629"
FT   VAR_SEQ         396..401
FT                   /note="Missing (in isoform TrkA-I)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_002900"
FT   MUTAGEN         527
FT                   /note="V->D: Loss of kinase activity."
FT                   /evidence="ECO:0000269|PubMed:9856458"
SQ   SEQUENCE   799 AA;  87868 MW;  D564E8801E8978F8 CRC64;
     MLRGQRHGQL GWHRPAAGLG GLVTSLMLAC ACAASCRETC CPVGPSGLRC TRAGTLNTLR
     GLRGAGNLTE LYVENQRDLQ RLEFEDLQGL GELRSLTIVK SGLRFVAPDA FHFTPRLSHL
     NLSSNALESL SWKTVQGLSL QDLTLSGNPL HCSCALLWLQ RWEQEDLCGV YTQKLQGSGS
     GDQFLPLGHN NSCGVPSVKI QMPNDSVEVG DDVFLQCQVE GQALQQADWI LTELEGTATM
     KKSGDLPSLG LTLVNVTSDL NKKNVTCWAE NDVGRAEVSV QVSVSFPASV HLGKAVEQHH
     WCIPFSVDGQ PAPSLRWFFN GSVLNETSFI FTQFLESALT NETMRHGCLR LNQPTHVNNG
     NYTLLAANPY GQAAASIMAA FMDNPFEFNP EDPIPVSFSP VDTNSTSRDP VEKKDETPFG
     VSVAVGLAVS AALFLSALLL VLNKCGQRSK FGINRPAVLA PEDGLAMSLH FMTLGGSSLS
     PTEGKGSGLQ GHIMENPQYF SDTCVHHIKR QDIILKWELG EGAFGKVFLA ECYNLLNDQD
     KMLVAVKALK ETSENARQDF HREAELLTML QHQHIVRFFG VCTEGGPLLM VFEYMRHGDL
     NRFLRSHGPD AKLLAGGEDV APGPLGLGQL LAVASQVAAG MVYLASLHFV HRDLATRNCL
     VGQGLVVKIG DFGMSRDIYS TDYYRVGGRT MLPIRWMPPE SILYRKFSTE SDVWSFGVVL
     WEIFTYGKQP WYQLSNTEAI ECITQGRELE RPRACPPDVY AIMRGCWQRE PQQRLSMKDV
     HARLQALAQA PPSYLDVLG
//
